 |
|
< Back to Participating Clinical Centers Menu
Oregon Health and Science University Web Site Contact InformationAlan Barker, MD [Download CV] RLDC Open Studies:5702: Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (MILES) Publications1: Eden E, Hammel J, Rouhani FN, Brantly ML, Barker AF, Buist AS, Fallat RJ, Stoller JK, Crystal RG, Turino GM. Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest. 2003 Mar;123(3):765-71. PMID: 12628876 [PubMed - indexed for MEDLINE] 2: Barker AF. Bronchiectasis. N Engl J Med. 2002 May 2;346(18):1383-93. Review. No abstract available. PMID: 11986413 [PubMed - indexed for MEDLINE] 3: Barker AF, Couch L, Fiel SB, Gotfried MH, Ilowite J, Meyer KC, O'Donnell A, Sahn SA, Smith LJ, Stewart JO, Abuan T, Tully H, Van Dalfsen J, Wells CD, Quan J. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):481-5. PMID: 10934074 [PubMed - indexed for MEDLINE] 4: Schluchter MD, Stoller JK, Barker AF, Buist AS, Crystal RG, Donohue JF, Fallat RJ, Turino GM, Vreim CE, Wu MC. Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):796-801. PMID: 10712324 [PubMed - indexed for MEDLINE] 5: O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest. 1998 May;113(5):1329-34. PMID: 9596315 [PubMed - indexed for MEDLINE] 6: Barker AF, Iwata-Morgan I, Oveson L, Roussel R. Pharmacokinetic study of alpha1-antitrypsin infusion in alpha1-antitrypsin deficiency. Chest. 1997 Sep;112(3):607-13. PMID: 9315791 [PubMed - indexed for MEDLINE] 7: Turino GM, Barker AF, Brantly ML, Cohen AB, Connelly RP, Crystal RG, Eden E, Schluchter MD, Stoller JK. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1718-25. PMID: 8970361 [PubMed - indexed for MEDLINE] 8: Barker AF. Bronchiectasis. Semin Thorac Cardiovasc Surg. 1995 Apr;7(2):112-8. Review. PMID: 7612755 [PubMed - indexed for MEDLINE] 9: Barker AF, Siemsen F, Pasley D, D'Silva R, Buist AS. Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration. Chest. 1994 May;105(5):1406-10. PMID: 8181327 [PubMed - indexed for MEDLINE] 10: Barker AF, Burgher LW, Plummer AL. Oxygen conserving methods for adults. Chest. 1994 Jan;105(1):248-52. Review. No abstract available. PMID: 8275741 [PubMed - indexed for MEDLINE] 11: Barker AF. Alpha 1-antitrypsin-deficiency-related emphysema. J Am Board Fam Pract. 1992 Sep-Oct;5(5):489-93. Review. PMID: 1414450 [PubMed - indexed for MEDLINE] 12: Barker AF, Hirshman CA, D'Silva R, Hanifin JM. Airway responsiveness in atopic dermatitis. J Allergy Clin Immunol. 1991 Apr;87(4):780-3. PMID: 2013672 [PubMed - indexed for MEDLINE] 13: Barker AF, Moseley JR, Glidewell BL. Components of a smoke-free hospital program. Arch Intern Med. 1989 Jun;149(6):1357-9. PMID: 2730253 [PubMed - indexed for MEDLINE] 14: Barker AF. Strategies in managing asthma. West J Med. 1989 Mar;150(3):303-8. Review. PMID: 2660411 [PubMed - indexed for MEDLINE] |
|||||||||||
Home | Glossary | Frequently Asked Questions | Contact Web Master | Accessibility | Disclaimer | Site Map |
||||||||||||
